Our pharmaceutical companies develop medicines that treat many of the world's most serious and prevalent diseases. These conditions include Alzheimer’s disease, anemia, autoimmune disorders (such as rheumatoid arthritis and psoriasis), cancer, cardiovascular disease, schizophrenia, epilepsy, infectious disease, migraine, and pain. In 2007, we invested $5.3 billion in research for new medicines to treat these and many other diseases.
Our pharmaceutical companies develop medicines that treat many of the world's most serious and prevalent diseases. These conditions include Alzheimer’s disease, anemia, autoimmune disorders (such as rheumatoid arthritis and psoriasis), cancer, cardiovascular disease, schizophrenia, epilepsy, infectious disease, migraine, and pain. In 2007, we invested $5.3 billion in research for new medicines to treat these and many other diseases.